Terms: = Prostate cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Diagnosis
25 results:
1. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive prostate cancer.
Darst BF; Saunders E; Dadaev T; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Wang Y; Patel AV; Albanes D; Weinstein SJ; Gnanapragasam V; Huff C; Couch FJ; Wolk A; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz MM; Schmidt JA; Travis RC; Key TJ; Stopsack KH; Mucci LA; Catalona WJ; Marosy B; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Conti DV; Kote-Jarai Z; Haiman CA
JAMA Oncol; 2023 Nov; 9(11):1514-1524. PubMed ID: 37733366
[TBL] [Abstract] [Full Text] [Related]
2. A critical analysis of deficiencies in the quality of information contained in prostate multiparametric MRI requests and reports.
Cullivan O; Roche E; Hegazy M; Taha M; Durkan G; O'Malley P; McCarthy P; Dowling CM
Ir J Med Sci; 2023 Feb; 192(1):27-31. PubMed ID: 35094231
[TBL] [Abstract] [Full Text] [Related]
3. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
[TBL] [Abstract] [Full Text] [Related]
4. Is Thiol/Disulphide homeostasis important in prostate cancer diagnosis?
Senel C; Aslan Y; Imamoglu MA; Karakoyunlu AN; Altinova S; Ozcan MF; Erdogan S; Balci M; Tuncel A
Arch Esp Urol; 2020 Nov; 73(9):819-825. PubMed ID: 33144536
[TBL] [Abstract] [Full Text] [Related]
5. Improving identification of candidates for lung cancer screening in a high risk population.
Waddle MR; Ko SJ; May J; Kaleem T; Miller DH; Stross WC; Malouff TD; Wert K; Cuthbert K; Landy R; Strong G; Vallow LA; Johnson MM
Lung Cancer; 2020 Oct; 148():79-85. PubMed ID: 32827761
[TBL] [Abstract] [Full Text] [Related]
6. Incidence and Mortality of Lung cancer Among Never Smokers in Relationship to Secondhand Smoking: Findings From the PLCO Trial.
Abdel-Rahman O
Clin Lung Cancer; 2020 Sep; 21(5):415-420.e2. PubMed ID: 32389507
[TBL] [Abstract] [Full Text] [Related]
7. Cost-Effectiveness Analysis of Supervised Exercise Training in Men with prostate cancer Previously Treated with Radiation Therapy and Androgen-Deprivation Therapy.
Edmunds K; Reeves P; Scuffham P; Galvão DA; Newton RU; Jones M; Spry N; Taaffe DR; Joseph D; Chambers SK; Tuffaha H
Appl Health Econ Health Policy; 2020 Oct; 18(5):727-737. PubMed ID: 32107736
[TBL] [Abstract] [Full Text] [Related]
8. Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical prostatectomy after an Initial Period of Surveillance.
Balakrishnan AS; Cowan JE; Cooperberg MR; Shinohara K; Nguyen HG; Carroll PR
J Urol; 2019 Sep; 202(3):506-510. PubMed ID: 30958738
[TBL] [Abstract] [Full Text] [Related]
9. Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT prostate multivariable model.
Thurtle DR; Greenberg DC; Lee LS; Huang HH; Pharoah PD; Gnanapragasam VJ
PLoS Med; 2019 Mar; 16(3):e1002758. PubMed ID: 30860997
[TBL] [Abstract] [Full Text] [Related]
10. Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant prostate cancer-A Systematic Literature Review and Pooling of Individual Participant Data.
Aly M; Hashim M; Heeg B; Liwing J; Leval A; Mehra M; Lawson J; Brookman-May SD; Akre O
Eur Urol Focus; 2019 Sep; 5(5):788-798. PubMed ID: 29627197
[TBL] [Abstract] [Full Text] [Related]
11. [Preliminary applicability evaluation of prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
[No Abstract] [Full Text] [Related]
12. Trends in Obesity Prevalence in Adults With a History of cancer: Results From the US National Health Interview Survey, 1997 to 2014.
Greenlee H; Shi Z; Sardo Molmenti CL; Rundle A; Tsai WY
J Clin Oncol; 2016 Sep; 34(26):3133-40. PubMed ID: 27458295
[TBL] [Abstract] [Full Text] [Related]
13. [Analysis of biochemical recurrence following radical prostatectomy].
Dai B; Chang K; Kong Y; Qu Y; Wang Y; Jia Z; Ye D; Wang C; Zhang H; Yang W
Zhonghua Wai Ke Za Zhi; 2015 Apr; 53(4):261-5. PubMed ID: 26269158
[TBL] [Abstract] [Full Text] [Related]
14. Population-based referrals for adjuvant radiotherapy after radical prostatectomy in men with prostate cancer: impact of randomized trials.
Quon H; Suderman D; Guilbert K; Lambert P; Bucher O; Ong A; Chowdhury A
Clin Genitourin Cancer; 2014 Feb; 12(1):e1-5. PubMed ID: 24571005
[TBL] [Abstract] [Full Text] [Related]
15. Is digoxin use for cardiovascular disease associated with risk of prostate cancer?
Wright JL; Hansten PD; Stanford JL
Prostate; 2014 Jan; 74(1):97-102. PubMed ID: 24318956
[TBL] [Abstract] [Full Text] [Related]
16. Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospital.
Nonzee NJ; McKoy JM; Rademaker AW; Byer P; Luu TH; Liu D; Richey EA; Samaras AT; Panucci G; Dong X; Simon MA
BMC Health Serv Res; 2012 Sep; 12():340. PubMed ID: 23009152
[TBL] [Abstract] [Full Text] [Related]
17. [Which factors allow to anticipate the diagnosis of prostate cancer in pin patients? A study on 546 patients].
Antonelli A; Tardanico R; Giovanessi L; Pesenti N; Gatti L; Zambolin T; Zani D; Simeone C; Cunico SC
Urologia; 2010; 77 Suppl 17():20-6. PubMed ID: 21678580
[TBL] [Abstract] [Full Text] [Related]
18. Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: a study on 546 patients.
Antonelli A; Tardanico R; Giovanessi L; Pesenti N; Gatti L; Zambolin T; Zani D; Cunico SC; Simeone C
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):173-6. PubMed ID: 21358754
[TBL] [Abstract] [Full Text] [Related]
19. Proximity ligation measurement of the complex between prostate specific antigen and alpha1-protease inhibitor.
Zhu L; Koistinen H; Landegren U; Stenman UH
Clin Chem; 2009 Sep; 55(9):1665-71. PubMed ID: 19643837
[TBL] [Abstract] [Full Text] [Related]
20. A prospective study of iodine status, thyroid function, and prostate cancer risk: follow-up of the First National Health and Nutrition Examination Survey.
Hoption Cann SA; Qiu Z; van Netten C
Nutr Cancer; 2007; 58(1):28-34. PubMed ID: 17571964
[TBL] [Abstract] [Full Text] [Related]
[Next]
